Medical Devices

Fuatilia
Elderly patient happily reading with restored central vision from the PRIMA wireless retinal implant in a clinical trial.
Àwòrán tí AI ṣe

Wireless PRIMA retinal implant improves central vision for many patients with advanced geographic atrophy, trial reports

Ti AI ṣe iroyin Àwòrán tí AI ṣe Ti ṣayẹwo fun ododo

A 2×2 millimeter wireless retinal implant system helped many people with advanced geographic atrophy due to age-related macular degeneration regain functional central vision in a multicenter European study, according to results published in The New England Journal of Medicine.

The FDA has cleared Dexcom’s Stelo Glucose Biosensor System for use by people ages 2 and older who do not use insulin. The decision, announced June 12, makes Stelo the first over-the-counter continuous glucose monitor approved for children.

Ti AI ṣe iroyin

Medartis Holding AG held an investor and media event in Basel on June 4 around the FESSH hand surgery congress. CEO Matthias Schupp welcomed attendees and outlined the company's strategy roadmap.

The U.S. Food and Drug Administration has approved a new device for detecting hypertension, integrating advanced sensor technology. This innovation aims to improve early diagnosis and management of the condition.

Ti AI ṣe iroyin Ti ṣayẹwo fun ododo

Recent developments in diabetes care include smarter insulin delivery systems and an AI-paired artificial pancreas, highlighted on September 11, 2025.

Ojú-ìwé yìí nlo kuki

A nlo kuki fun itupalẹ lati mu ilọsiwaju wa. Ka ìlànà àṣírí wa fun alaye siwaju sii.
Kọ